Strax

Autospela

MARS: mutation-adjusted risk score for advanced systemic mastocytosis

1 Visningar • 07/09/23
Dela med sig
Bädda in
administrator
administrator
Prenumeranter
0

Andreas Reiter, MD, University Medical Centre, Mannheim, Germany, discusses how a mutation-adjusted risk score (MARS) may improve treatment stratification for advanced systemic mastocytosis (AdvSM). This interview took place at the Myeloproliferative Neoplasms Advances Day 2019 in London, UK.

Visa mer
0 Kommentarer sort Sortera efter
Facebook-kommentarer

Strax

Autospela